Real Estate & Construction » Real Estate | Microlin Bio Inc.

Microlin Bio Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
Sales/Revenue
-
8.50
SG&A Expense
76.60
217.50
EBIT
76.60
209.00
Unusual Expense
-
125.00
Interest Expense
31.30
139.60
Pretax Income
107.90
223.60
Consolidated Net Income
107.90
223.60
Net Income
107.90
223.60
Net Income After Extraordinaries
107.90
223.60
Net Income Available to Common
107.90
223.60
EPS (Basic)
0.01
0.02
Basic Shares Outstanding
8,628.20
9,100.00
EPS (Diluted)
0.01
0.02
Diluted Shares Outstanding
8,628.20
9,100.00
EBITDA
76.60
209.00

About Microlin Bio

View Profile
Address
358 Frankfort Street
New York New York 94104
United States
Employees -
Website http://www.microlinbio.com
Updated 09/14/2018
Microlin Bio, Inc. is a biopharmaceutical company, which engages in the development of microribonucleic acid therapeutics. It offers programs for cancer therapeutics and delivery platform technology. The company was founded by Joseph Hernandez on January 27, 2013 and is headquartered in New York, NY.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.